Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06739798

Comparison of Binocular Spectacle Prescription Versus Patching Therapy in Refractive Amblyopia Patients

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
5 Years – 18 Years
Healthy volunteers
Accepted

Summary

This study will examine on Refractive Amblyopia patients, whose amblyopia started due to longstanding uncorrected refractive errors.

Detailed description

There will be a comparison of two treatment methods i.e. Patching and Binocular Spectacle Prescription used to cure amblyopia patients. In binocular spectacle correction, we will slightly blur the good eye and fully correct the amblyopic eye so that binocular functions stimulate and improve after the treatment. Literature suggests that Patching improve monocular functions but there is no significant improvement in binocular functions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTExp GroupBinocular Spectacle prescription are therapeutic tools used to correct refractive errors in visually impaired patients. They improve Visual acuity as well as other visual functions in Amblyopic and visual impairment patients. They stimulate weaker eye to generate visual impulse and stimulate visual cortex to improve stereopsis and fusion.
DIAGNOSTIC_TESTControl GroupPatching therapy is a gold standard tool used world wide to correct visual acuity in amblyopic patients. This tool is used by occluding stronger eye with a patch or bandage or fogging lens and stimulating amblyopic eye to generate visual stimulus to motivate visual cortex.

Timeline

Start date
2024-04-01
Primary completion
2024-09-01
Completion
2025-03-30
First posted
2024-12-18
Last updated
2024-12-18

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06739798. Inclusion in this directory is not an endorsement.

Comparison of Binocular Spectacle Prescription Versus Patching Therapy in Refractive Amblyopia Patients (NCT06739798) · Clinical Trials Directory